Patient info

Desloratadine Glenmark 5 mg tablets – patient leaflet, side effects, dosage

Updated:
Key facts
Status:
Prescription only (POM)
Medicine strength:
5 mg
Contains active substance:

Patient leaflet - Desloratadine Glenmark 5 mg tablets

1. What Desloratadine 5 mg Tablets are and what they are used for

What Desloratadine 5 mg Tablets is

Desloratadine 5 mg Tablets contain desloratadine which is an antihistamine.

How Desloratadine 5 mg Tablets works

Desloratadine 5 mg Tablets is an antiallergy medicine that does not make you drowsy. It helps control your allergic reaction and its symptoms.

When Desloratadine 5 mg Tablets should be used

Desloratadine relieves symptoms associated with allergic rhinitis (inflammation of the nasal passages caused by an allergy, hay fever or allergy to dust mites) in adults and adolescents 12 years of age and older. These symptoms include sneezing, runny or itchy nose, itchy palate, and itchy, red or watery eyes.

Desloratadine is also used to relieve symptoms of urticaria (a skin condition caused by an allergy). These symptoms include itching and hives.

Relief of these symptoms lasts a full day and helps you to resume your normal daily activities and sleep.

2. What you need to know before you take Desloratadine 5 mg Tablets

Do not take Desloratadine 5 mg Tablets if

  • if you are allergic to desloratadine, or any of the other

    ingredients of this medicine (listed in section 6) or to loratadine.

Warnings – talk to your doctor, pharmacist or nurse

Talk to your doctor, pharmacist or nurse before taking Desloratadine:

  • if you have poor kidney function.
  • If you have a medical or familial history of seizures. Use in children and adolescents

Do not give this medicine to children less than 12 years of age.

Other medicines and Desloratadine

There are no known interactions of desloratadine with other medicines.

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. Desloratadine with food, drink and alcohol

Desloratadine Glenmark may be taken with or without a meal.

Use caution when taking Desloratadine Glenmark with alcohol.

Pregnancy, breast-feeding and fertility

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor, or pharmacist for advice before taking this medicine. Taking Desloratadine is not recommended if you are pregnant or nursing a baby.

Fertility

There is no data available on male/female fertility. Driving and using machines

At the recommended dose, this medicine is not expected to affect your ability to drive or use machines. Although most people do not experience drowsiness, it is recommended not to engage in activities requiring mental alertness, such as driving a car or operating machinery until you have established your own response to the medicinal product. Desloratadine tablets contain lactose

If you have been told by your doctor that you have an intolerance to some sugars, talk to your doctor before taking this medicinal product.

3. How to take Desloratadine 5 mg Tablets

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

Adults and adolescents aged 12 years of age and over

The recommended dose is one tablet once a day, with water with or without food.

This medicine is for oral use.

Swallow the tablet whole.

Regarding the duration of treatment, your doctor will determine the type of allergic rhinitis you are suffering from and will decide for how long you should take Desloratadine Glenmark.

If your allergic rhinitis is intermittent (presence of symptoms for less than 4 days per week or for less than 4 weeks), your doctor will recommend you a treatment schedule that will depend on the evaluation of the history of your disease. If your allergic rhinitis is persistent (presence of symptoms for 4 days or more per week and for more than 4 weeks), your doctor may recommend you a longer term treatment. For urticaria, the duration of treatment may be variable from patient to patient and therefore you should follow the instructions of your doctor.

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT

Desloratadine 5 mg tablets

180 mm

DATE: 7-11-24

If you take more Desloratadine 5 mg Tablets than you should

Take Desloratadine only as it is prescribed for you. No serious problems are expected with accidental overdose. However, if you take more desloratadine than you were told to, tell your doctor, pharmacist or nurse immediately. If you forget to take Desloratadine 5 mg Tablets

If you forget to take your dose on time, take it as soon as possible, then go back to your regular dosing schedule. Do not take a double dose to make up for a forgotten dose. If you stop taking Desloratadine 5 mg Tablets

If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

During the marketing of Desloratadine 5 mg Tablets, cases of severe allergic reactions (difficulty in breathing, wheezing, itching, hives and swelling of the face, tongue or throat) have been reported very rarely. If you notice any of these serious side effects, stop taking the medicine and seek urgent medical advice straight away.

In clinical studies with Desloratadine 5 mg Tablets, the following side effects were reported as:

Common: the following may affect up to 1 in 10 people

  • fatigue
  • dry mouth
  • headache

Adults

During the marketing of Desloratadine 5 mg Tablets, the following side effects were reported as:

Very rare: the following may affect up to 1 in 10,000 people

  • severe allergic

    reactions

    • rash ● pounding or

      irregular heartbeat

  • fast heartbeat ● stomach ache ● feeling sick (nausea)
  • vomiting ● upset stomach ● diarrhoea
  • dizziness ● drowsiness ● inability to sleep
  • muscle pain ● hallucinations ● seizures
  • restlessness with

    increased body

    movement

    • liver

      inflammation

      • abnormal liver function tests

Not known: frequency cannot be estimated from the available data

  • unusual weakness ● yellowing of the skin and/or eyes
  • increased sensitivity of the skin to the sun, even in case of hazy sun, and to UV light, for instance to UV lights of a solarium
  • change in the way the heart beats
  • abnormal behaviour
  • aggression
  • weight increased
  • increased appetite
  • depressed mood
  • dry eyes

    Children

    Not known: frequency cannot be estimated from the available data

    • slow heartbeat
    • change in the way the heart beats
    • abnormal behaviour
    • aggression
    • depressed mood
    • dry eyes

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via Yellow Card Scheme (Website: www.mhra.gov.uk/ yellowcard). By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Desloratadine 5 mg Tablets

Keep out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. The expiry date refers to the last day of that month.

This medicine does not require any special storage conditions.

Do not use this medicine if you notice any changes in the appearance of the tablets.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.

6. Contents of the pack and other information.

What Desloratadine 5 mg tablets contain

  • The active substance is desloratadine. Each tablet contains 5 mg desloratadine
  • The other ingredients of the tablet are Microcrystalline cellulose, Lactose monohydrate, Maize starch, Silica, colloidal anhydrous; Magnesium stearate

What Desloratadine 5 mg tablets look like and contents of the pack

Desloratadine tablets are off-white to light-pink, circular, biconvex tablets with ‘L5’ engraved on one side and plain on the other side.

The tablets are available in blister packs containing 7, 10, 14, 15, 20, 28, 30, 50 or 100 tablets. Not all pack sizes may be marketed.

Marketing Authorisation Holder:

Glenmark Pharmaceuticals Europe Limited

Laxmi House, 2B Draycott Avenue

Harrow, Middlesex HA3 0BU, UK

Manufacturers:

Glenmark Pharmaceuticals s.r.o

Fibichova 143, 566 17 Vysoké Mýto,

Czech Republic

Glenmark Pharmaceuticals Europe Limited

Building 2, Croxley Green Business Park,

Croxley Green, Hertfordshire, WD18 8YA,

United Kingdom

This leaflet was last revised in 11/2024.

180 mm

DATE: 7-11-24

PRODUCT: Amends: Approval:

Indesign CS 5

GM2522

Desloratadine 5 mg tablets NL

PIL

7.11.24

180 x 230 mm

1

Leaflet (PIL)

N

Times New Roman ALL 9 pts body copy (min)

Internal proof approval

External proof approval Signed (digitally)

Signed (digitally)

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 25258/0052

Last revision stated in the text: November 2024 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Desloratadine Glenmark 5 mg tablets

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Desloratadine
Strength 5 mg
Pharmaceutical form Oral tablet
How is it taken Oral
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Drug group (ATC)
  1. R Respiratory system drugs
    1. R06 Antihistamines for systemic use
      1. R06A Antihistamines for systemic use
        1. R06AX Other antihistamines for systemic use
          1. R06AX27 desloratadine
Marketing authorisation PL 25258/0052
Codes BNF 03040100

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.